Summary

Global Hanta Virus Market is valued approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2021-2027. Hanta Virus is a disease that is caused by rodent causes febrile haemorrhagic diseases which can often cause kidney damage or failure. The virus can spread when virus contain rodent urine, droppings, or saliva are stirred in the air. The increasing cases of hantavirus is likely to increase the market growth for the market in the forecasted period. For Instance: as per the Gavi the Vaccine Alliance, in 2021, reported that there are approximately 200,00 new cases each year globally. Also, rising awareness about the Hanta virus which leads to the adoption & demand for Hanta Virus is likely to increase the market growth during the forecast period. On the other hand, there is no specialized medication or vaccine for Hanta virus market which is the main challenge associated with the market.

The key regions considered for the global Hanta Virus market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. North America accounts for the largest market share owing to the proper investment in surveillance for hanta virus cases. Whereas, Asia-Pacific is anticipated to exhibit highest growth rate for the forecast period 2021-2027. Factors such as increasing government investment in healthcare sector would create lucrative growth prospects for the Hanta Virus market across Asia-Pacific region.

Major market player included in this report are:
PharmJet
Taj Pharmaceutical Limited.
Lupin
Merck Sharp & Dohme Corp.
Genentech, Inc.
Aurobindo Pharma
Zydus Pharmaceuticals, Inc.
F. Hoffmann-La Roche Ltd.
Kadmon Pharmaceuticals
Schering Corp

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Symptoms:
Fever
Body Aches
Hemolytic Anaemia
Thrombocytopenia
Abdominal Pain
Hantavirus Pulmonary Syndrome (HPS)
Haemorrhagic Fever with Renal Syndrome (HFRS)
By Mode of Transmission:
Urine
Faces
Salvia
Rodent Bite
Airborne Particles Containing These Excretions
By Drug Type:
Branded
Generic
By Route of Administration:
Oral
Injectable
Others
By End Uses:
Hospitals
Academic Research Institutes
Others
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027

Target Audience of the Global Hanta Virus Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

ページTOPに戻る

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Hanta Virus Market, by Region, 2019-2027 (USD Billion)
1.2.2. Hanta Virus Market, by Symptoms, 2019-2027 (USD Billion)
1.2.3. Hanta Virus Market, by Mode of Transmission, 2019-2027 (USD Billion)
1.2.4. Hanta Virus Market, by Drug Type, 2019-2027 (USD Billion)
1.2.5. Hanta Virus Market, by Route of Administration, 2019-2027 (USD Billion)
1.2.6. Hanta Virus Market, by End Uses, 2019-2027 (USD Billion)
1.2.7. Hanta Virus Market, by Distribution Channel, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Hanta Virus Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Hanta Virus Market Dynamics
3.1. Hanta Virus Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing in new cases
3.1.2. Market Challenges
3.1.2.1. Lack of proper medication
3.1.3. Market Opportunities
3.1.3.1. Increasing in awareness about the virus
Chapter 4. Global Hanta Virus Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Hanta Virus Market, by Symptoms
6.1. Market Snapshot
6.2. Global Hanta Virus Market by Symptoms, Performance - Potential Analysis
6.3. Global Hanta Virus Market Estimates & Forecasts by Symptoms 2018-2027 (USD Billion)
6.4. Hanta Virus Market, Sub Segment Analysis
6.4.1. Fever
6.4.2. Body Aches
6.4.3. Hemolytic Anaemia
6.4.4. Thrombocytopenia
6.4.5. Abdominal Pain
6.4.6. Hantavirus Pulmonary Syndrome (HPS)
6.4.7. Haemorrhagic Fever with Renal Syndrome (HFRS)
Chapter 7. Global Hanta Virus Market, by Mode of Transmission
7.1. Market Snapshot
7.2. Global Hanta Virus Market by Mode of Transmission, Performance - Potential Analysis
7.3. Global Hanta Virus Market Estimates & Forecasts by Mode of Transmission 2018-2027 (USD Billion)
7.4. Hanta Virus Market, Sub Segment Analysis
7.4.1. Urine
7.4.2. Faces
7.4.3. Salvia
7.4.4. Rodent Bite
7.4.5. Airborne Particles Containing These Excretions
Chapter 8. Global Hanta Virus Market, by Drug Type
8.1. Market Snapshot
8.2. Global Hanta Virus Market by Drug Type, Performance - Potential Analysis
8.3. Global Hanta Virus Market Estimates & Forecasts by Drug Type2018-2027 (USD Billion)
8.4. Hanta Virus Market, Sub Segment Analysis
8.4.1. Branded
8.4.2. Generic
Chapter 9. Global Hanta Virus Market, by Route of Administration
9.1. Market Snapshot
9.2. Global Hanta Virus Market by Route of Administration, Performance - Potential Analysis
9.3. Global Hanta Virus Market Estimates & Forecasts by Route of Administrations 2018-2027 (USD Billion)
9.4. Hanta Virus Market, Sub Segment Analysis
9.4.1. Oral
9.4.2. Injectable
9.4.3. Others
Chapter 10. Global Hanta Virus Market, by End Uses
10.1. Market Snapshot
10.2. Global Hanta Virus Market by End Uses, Performance - Potential Analysis
10.3. Global Hanta Virus Market Estimates & Forecasts by End Uses 2018-2027 (USD Billion)
10.4. Hanta Virus Market, Sub Segment Analysis
10.4.1. Hospitals
10.4.2. Academic Research Institutes
10.4.3. Others
Chapter 11. Global Hanta Virus Market, by Distribution Channel
11.1. Market Snapshot
11.2. Global Hanta Virus Market by Distribution Channel, Performance - Potential Analysis
11.3. Global Hanta Virus Market Estimates & Forecasts by Distribution Channel 2018-2027 (USD Billion)
11.4. Hanta Virus Market, Sub Segment Analysis
11.4.1. Hospital Pharmacy
11.4.2. Retail Pharmacy
11.4.3. Others
Chapter 12. Global Hanta Virus Market, Regional Analysis
12.1. Hanta Virus Market, Regional Market Snapshot
12.2. North America Hanta Virus Market
12.2.1. U.S. Hanta Virus Market
12.2.1.1. Symptoms breakdown estimates & forecasts, 2018-2027
12.2.1.2. Mode of Transmission breakdown estimates & forecasts, 2018-2027
12.2.1.3. Drug Type breakdown estimates & forecasts, 2018-2027
12.2.1.4. Route of Administration breakdown estimates & forecasts, 2018-2027
12.2.1.5. End Uses breakdown estimates & forecasts, 2018-2027
12.2.1.6. Distribution Channel breakdown estimates & forecasts, 2018-2027
12.2.2. Canada Hanta Virus Market
12.3. Europe Hanta Virus Market Snapshot
12.3.1. U.K. Hanta Virus Market
12.3.2. Germany Hanta Virus Market
12.3.3. France Hanta Virus Market
12.3.4. Spain Hanta Virus Market
12.3.5. Italy Hanta Virus Market
12.3.6. Rest of Europe Hanta Virus Market
12.4. Asia-Pacific Hanta Virus Market Snapshot
12.4.1. China Hanta Virus Market
12.4.2. India Hanta Virus Market
12.4.3. Japan Hanta Virus Market
12.4.4. Australia Hanta Virus Market
12.4.5. South Korea Hanta Virus Market
12.4.6. Rest of Asia Pacific Hanta Virus Market
12.5. Latin America Hanta Virus Market Snapshot
12.5.1. Brazil Hanta Virus Market
12.5.2. Mexico Hanta Virus Market
12.6. Rest of The World Hanta Virus Market

Chapter 13. Competitive Intelligence
13.1. Top Market Strategies
13.2. Company Profiles
13.2.1. PharmJet
13.2.1.1. Key Information
13.2.1.2. Overview
13.2.1.3. Financial (Subject to Data Availability)
13.2.1.4. Product Summary
13.2.1.5. Recent Developments
13.2.2. Taj Pharmaceutical Limited.
13.2.3. Lupin
13.2.4. Merck Sharp & Dohme Corp.
13.2.5. Genentech, Inc.
13.2.6. Aurobindo Pharma
13.2.7. Zydus Pharmaceuticals, Inc.
13.2.8. F. Hoffmann-La Roche Ltd.
13.2.9. Kadmon Pharmaceuticals
13.2.10. Schering Corp
Chapter 14. Research Process
14.1. Research Process
14.1.1. Data Mining
14.1.2. Analysis
14.1.3. Market Estimation
14.1.4. Validation
14.1.5. Publishing
14.2. Research Attributes
14.3. Research Assumption